# An oncolytic virus–T cell chimera for cancer immunotherapy

*PRI Rank #16 · Topics and Trends in Most Cited Virus-based gene therapy research Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/virus-based-gene-therapy-research/2026/rank-16*

| Field | Value |
| --- | --- |
| Rank | #16 |
| 18m citations | 42 |
| Journal | Nature Biotechnology |
| Year | 2024 |
| DOI | 10.1038/s41587-023-02118-7 |
| Corresponding authors | Ping Yuan |
| Institution | Zhejiang University, China |

**Ranking page:** [Topics and Trends in Most Cited Virus-based gene therapy research Papers, Class of 2026](https://pri.pepkio.com/top-papers/virus-based-gene-therapy-research/2026)

**Paper link:** [10.1038/s41587-023-02118-7](https://doi.org/10.1038/s41587-023-02118-7)

## Topics

Oncolytic virus · T cell chimera · Cancer immunotherapy · viral vector engineering · Adoptive cell therapy · tumor-infiltrating lymphocytes · Oncolytic virotherapy · immune cell delivery · combination immunotherapy · engineered T cells · Therapeutic viruses · tumor microenvironment · Therapeutic viruses · Adoptive cell therapy

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Virus-based gene therapy research Papers, Class of 2026. https://pri.pepkio.com/top-papers/virus-based-gene-therapy-research/2026. Accessed 2026-07-21.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```